[1] Chen W, Zheng R, Baade PD, et al.Cancer statistics in China, 2015[J]. CA Cancer J Clin,2016,66(2):115-132. [2] Fuentes E, Ahmad R, Hong TS, et al.Adjuvant therapy completion rates in patients with gastric cancer undergoing perioperative chemotherapy versus a surgery-first approach[J]. J Gastrointest Surg,2016,20(1):172-179. [3] Al-Batran SE, Pauligk C, Homann N, et al.LBA-008Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) as perioperative treatment of resectable gastric or gastro-esophageal junction adenocarcinoma: The multicenter, randomized phase 3 FLOT4 trial (German Gastric Group at AIO)[J]. Ann Oncol,2017,28(suppl_3). doi: 10.1093/annonc/mdx302.007. [4] Washington K.7th edition of the AJCC cancer staging manual: stomach[J]. Ann Surg Oncol,2010,17(12):3077-3079. [5] 李国立, 郑玲, 刘福坤, 等. 胃癌淋巴结转移的CT分组定位诊断法[J]. 外科理论与实践,2003,8(3):226-228,239. [6] Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition[J]. Gastric Cancer,2011,14(2):101-112. [7] Eisenhauer EA, Therasse P, Bogaerts J, et al.New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)[J]. Eur J Cancer,2009,45(2):228-247. [8] Zhang H, Pan Z, Du L, et al.Advanced gastric cancer and perfusion imaging using a multidetector row compu-ted tomography: correlation with prognostic determinants[J]. Korean J Radiol,2008,9(2):119-127. [9] Han K, Claret L, Piao Y, et al.Simulations to predict clinical trial outcome of bevacizumab plus chemotherapy vs. chemotherapy alone in patients with first-line gastric cancer and elevated plasma VEGF-A[J]. CPT Pharmacometrics Syst Pharmacol,2016,5(7):352-358. [10] Pavlakis N, Sjoquist KM, Martin AJ, et al.Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): a multinational placebo-controlled phase Ⅱ trial[J]. J Clin Oncol.2016,34(23):2728-2735. [11] Moon WJ, Jung SL, Lee JH, et al.Benign and malignant thyroid nodules: US differentiation--multicenter retrospective study[J]. Radiology,2008,247(3):762-770. [12] Yao J, Yang ZG, Chen HJ, et al.Gastric adenocarcinoma: can perfusion CT help to noninvasively evaluate tumor angiogenesis?[J]. Abdom Imaging,2011,36(1):15-21. [13] Matsui H, Anno H, Uyama I, et al.Relatively small size linitis plastica of the stomach: multislice CT detection of tissue fibrosis[J]. Abdom Imaging,2007,32(6):694-697. [14] Silva AC, Morse BG, Hara AK, et al.Dual-energy (spectral) CT: applications in abdominal imaging[J]. Radiographics,2011,31(4):1031-1050. [15] Lai X, Jiang Y, Zhang B, et al.Preoperative sonographic features of follicular thyroid carcinoma predict biological behavior: A retrospective study[J]. Medicine,2018,97(41):e12814. [16] 田墨涵, 于丽娟, 秦誉, 等. 结直肠癌的代谢体积与微血管密度和血行转移的关系[J]. 中华肿瘤杂志,2015, 37(7):521-525. [17] Pacelli F, Papa V, Caprino P, et al.Proximal compared with distal gastric cancer: multivariate analysis of prognostic factors[J]. Am Surg,2001,67(7):697-703. [18] Kodama M, Ishikawa K, Koyama H, et al.Study on the lymphatic flow of the lower gastric region for radical lymphadenectomy in advanced lower gastric cancer[J]. Nihon Geka Gakkai Zasshi,1988,89(7):1008-1013. [19] Li C, Oh SJ, Kim S, et al.Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer[J]. Oncology,2009,77(3-4):197-204. [20] Fischbach W, Goebeler-Kolve ME, Dragosics B, et al.Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series[J]. Gut,2004,53(1):34-37. |